Evidence map›Paper›PMID 40361362›Full record

ArticleCancers2025

Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8

Philip B Emmerich, Tonela Qyli, Katherine A Johnson, Somak Chaudhuri, Kristen M Clark, Nathaniel B Verhagen, Mitchell G Depke, Linda Clipson, Cheri A Pasch, Athanasios Papadas and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Philip B EmmerichDivision of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
Tonela QyliDivision of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
Katherine A JohnsonDivision of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0002-6335-7782
Somak ChaudhuriDivision of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
Kristen M ClarkDivision of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
Nathaniel B VerhagenDivision of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0002-8422-839X
Mitchell G DepkeDivision of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
Linda ClipsonMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, WI 53705, USA.
Cheri A PaschUniversity of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0009-0005-9683-7378
Athanasios PapadasCellular and Molecular Pathology Graduate Program, Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
Mark E BurkardDivision of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
Kari B WisinskiDivision of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0003-3535-0652
Stephanie M McGregorDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
Fotis AsimakopoulosDivision of Blood and Marrow Transplantation and Moores Cancer Center, University of California-San Diego, La Jolla, CA 92093, USA.
Dustin A DemingDivision of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
Optical imaging to predict cell-level genetic heterogeneity and treatment sensitivity in colorectal cancerR37CA226526 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI DEMING, DUSTIN A · 2018 to 2024
$4.2M
Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoidsR01CA272855 · NCI · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI Dustin A Deming, Melissa Caroline Skala · 2023 to 2026
$3.1M
Tumor matrix remodeling in anti-myeloma immunity and immunotherapyR01CA252937 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ASIMAKOPOULOS, FOTIOS · 2020 to 2024
$2.5M
Funk Out Cancer NANCI NIH HHS P30 CA014520NCI NIH HHS R01 CA252937NCI NIH HHS R01 CA272855NCI NIH HHS R37 CA226526NCI NIH HHS T32 CA009135
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerCD8+ TILsestrogen receptorversicanversikine

Identifiers

PMID40361362
PMCPMC12070914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.